{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:34:02Z","timestamp":1792010042820,"version":"4.4.0"},"reference-count":63,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2017,8,18]]},"DOI":"10.1080\/09546634.2016.1277179","type":"journal-article","created":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T18:09:06Z","timestamp":1482775746000},"page":"476-483","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":47,"title":["Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature"],"prefix":"10.1080","volume":"28","author":[{"given":"Aniseh","family":"Samadi","sequence":"first","affiliation":[{"name":"Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Ahmad Nasrollahi","sequence":"additional","affiliation":[{"name":"Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Hashemi","sequence":"additional","affiliation":[{"name":"Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Nassiri Kashani","sequence":"additional","affiliation":[{"name":"Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Firooz","sequence":"additional","affiliation":[{"name":"Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,1,22]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051113-024537"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00644.x"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.07.038"},{"key":"CIT0004","volume-title":"FDA: FDA approves Xeljanz for rheumatoid arthritis","year":"2012"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002028"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/vde.12047"},{"key":"CIT0007","unstructured":"FDA: Apoquel oclacitinib tablet dogs. Freedom of information summary: original new animal drug application. NADA 141-345. 2013 [Internet]. Washington: US food and drug administration; 2012 Nov 7. Available from: http:\/\/www.fda.gov\/downloads\/AnimalVeterinary\/Products\/ApprovedAnimalDrugProducts\/FOIADrugSummaries\/UCM338132.pdf. Accessed November 25, 2016."},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2014.09.006"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12128"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164080"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S82599"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/283617"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12265"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.167"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2012.10.018"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1038\/jidsymp.2013.29"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.25"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11168.x"},{"key":"CIT0019","first-page":"252","volume":"13","author":"Menter A","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62113-9"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13551"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.013"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12266"},{"key":"CIT0024","first-page":"777","volume":"14","author":"Ports WC","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1186\/s12895-016-0051-4"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.12.018"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13994"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13745"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14403"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.5.514"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.4161\/jkst.24137"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14871"},{"key":"CIT0033","unstructured":"ClinicalTrials.gov: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis [Internet]. Washington: U.S. National Institutes of Health; 2015 Oct 14; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02576938. Accessed November 25, 2016."},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.10.031"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-5-1"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1500973"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.260"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2491."},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13060"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3645"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1159\/000445182"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13598"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89776"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.09.007"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89790"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.02.015"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.3772"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2010.01139.x"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02059.x"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007811"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.1520"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.09.073"},{"key":"CIT0053","unstructured":"ClinicalTrials.gov: Open Label Phase 2 Proof-of-concept Pilot Trial of Topical Ruxolitinib in Repigmenting Adult Patients with Vitiligo [Internet]. Washington: U.S. National Institutes of Health; 2015 Oct 14. Available from: https:\/\/clinicaltrials.gov\/show\/NCT02809976. Accessed June 20, 2016."},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0166-x"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13915"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1412997"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2016.1145543"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.10.033"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.115.223784"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S62879"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis269"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12517"},{"key":"CIT0063","unstructured":"FDA: Approval package for tofactinib, NDA 20-3214\/S002 [Internet]. Washington: US food and drug administration; 2013 Nov 18. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2013\/203214Orig1s002.pdf. Accessed November 25, 2016."}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09546634.2016.1277179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T18:58:33Z","timestamp":1661194713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09546634.2016.1277179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,22]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,8,18]]}},"alternative-id":["10.1080\/09546634.2016.1277179"],"URL":"https:\/\/doi.org\/10.1080\/09546634.2016.1277179","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}